Appearance
Liquid
216974-75-3
C6638H10160N1720O2108S44
149,146.82 g/mol
Bevacizumab can inhibit tumor growth in a few different ways including inhibiting new blood vessel growth, altering vascular function and blood flow in tumor, and regression of newly formed tumor vasculature.
≤30°C
Bevacizumab is effective at treating metastatic colon cancer, lung cancers, renal cancers, ovarian cancers, and breast cancer.
Liquid